Beximco Pharmaceuticals Limited Profit Margin

Beximco Pharmaceuticals Limited (BXP.L) currently reports a profit margin of 16.04% as of March 2026. That compares with 13.99% in the prior-year period — up 14.6% year over year. That is above the sector sector average of 13.23%. Use the charts on this page to explore Beximco Pharmaceuticals Limited's profit margin history and peer comparisons.

Beximco Pharmaceuticals Limited's profit margin increased from 13.99% to 16.04% — a 14.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Beximco Pharmaceuticals Limited's profit margin of 16.04% is higher than the its sector sector average of 13.23%. That is roughly 21.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Beximco Pharmaceuticals Limited's current 16.04% should be judged against industry norms (sector average: 13.23%) and against BXP.L's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 16.04%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Beximco Pharmaceuticals Limited, and consider following BXP.L for alerts when major investors trade the stock.